GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (OSL:AZT) » Definitions » Other Net Income (Loss)

ArcticZymes Technologies ASA (OSL:AZT) Other Net Income (Loss) : kr0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is ArcticZymes Technologies ASA Other Net Income (Loss)?

ArcticZymes Technologies ASA's Other Net Income (Loss) for the three months ended in Dec. 2024 was kr0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.0 Mil.

ArcticZymes Technologies ASA's quarterly Other Net Income (Loss) stayed the same from Jun. 2024 (kr0.0 Mil) to Sep. 2024 (kr0.0 Mil) but then increased from Sep. 2024 (kr0.0 Mil) to Dec. 2024 (kr0.0 Mil).

ArcticZymes Technologies ASA's annual Other Net Income (Loss) declined from Dec. 2022 (kr0.0 Mil) to Dec. 2023 (kr0.0 Mil) and declined from Dec. 2023 (kr0.0 Mil) to Dec. 2024 (kr-0.0 Mil).


ArcticZymes Technologies ASA Other Net Income (Loss) Historical Data

The historical data trend for ArcticZymes Technologies ASA's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArcticZymes Technologies ASA Other Net Income (Loss) Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.36 - - - -

ArcticZymes Technologies ASA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ArcticZymes Technologies ASA Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ArcticZymes Technologies ASA Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of ArcticZymes Technologies ASA's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


ArcticZymes Technologies ASA Business Description

Traded in Other Exchanges
Address
Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.

ArcticZymes Technologies ASA Headlines

No Headlines